RESUMEN
BACKGROUND: Limited research is available on the perspectives of patients with cancer regarding integration of complementary medicine (CM) in conventional supportive cancer care. The purpose of this study was to explore patients' perspectives concerning CM integration within conventional oncology settings. PATIENTS AND METHODS: A 27-item questionnaire was constructed and administered to a convenient sample of Arab patients receiving cancer care in three oncology centers in northern Israel. RESULTS: Of the 324 respondents (94.7% response rate), 124 of 313 (39.6%) reported the use of CM for cancer-related outcomes. A logistic regression model indicated that CM was used with active chemo- or radiotherapy treatment [EXP [B], 2.926, 95% confidence interval (CI) 1.276-6.708; P=0.011] and a higher degree of spiritual quest (EXP [B], 3.425, 95% CI 1.042-11.253; P=0.043). Herbal medicine was the leading CM modality (87.9% of CM users), which included the use of 28 plants and traditional remedies, of which 17 were used to improve QOL, with 5 of the herbs having potential interactions with chemotherapy. 83.1% of respondents stated that they would consult with a CM provider if CM were to be integrated into the oncology department. Patients' expectation of CM consultation was clearly associated with expectations of QOL improvement, coping with cancer, and alleviating chemotherapy's side-effects when compared with expectations of cancer cure (P<0.0001). The three leading concerns which patients expected to be improved by integrative CM treatment were gastrointestinal symptoms (63.2%), fatigue (51.9%), and pain (40.5%). CONCLUSIONS: Integrative CM consultations should focus on the improvement of QOL concomitant with safety concerns regarding potential drug-herb interactions. The need to integrate a nonjudgmental yet evidence-based CM consultation service may also be applicable to oncology institutions challenged with culturally diverse populations with a high prevalence of traditional medicine use.
Asunto(s)
Neoplasias/terapia , Árabes , Humanos , Medicina Integrativa , Israel , Medicina Tradicional , Servicio de Oncología en Hospital , Calidad de Vida , Encuestas y CuestionariosRESUMEN
BACKGROUND: Based on traditional, historical, ethnobotanical, laboratory, and clinical findings, we present research framework aiming to identify Middle Eastern herbs that are worthy of further research for their anticancer potential. METHODS: A comprehensive research project was developed by a multinational team comprising family physicians, medicine specialists, oncologists, an Islamic medicine history specialist, a traditional medicine ethnobotanist, and a basic research scientist. The project followed two consecutive phases: (i) historical and ethnobotanical search for cancer-related keywords and (ii) Medline search for in vitro and in vivo studies. RESULTS: This search yielded 44 herbs associated with cancer care. The Medline search yielded 34 herbs of which 9 herbs were reported in various clinical studies. CONCLUSIONS: This multidisciplinary survey was found to be a valuable way to identify herbs with potential clinical significance in cancer care. Based on this pilot study, it is suggested that the Middle East can serve as a valuable region for future multicultural-oriented cancer research.
Asunto(s)
Medicina Tradicional/métodos , Neoplasias/tratamiento farmacológico , Fitoterapia/métodos , Plantas Medicinales , Antineoplásicos Fitogénicos , Etnobotánica , Humanos , Medio OrienteRESUMEN
To assess the long-term effect of vitamin D or calcium supplementation on the skeletal metabolism of aging laboratory rodents, 1.5-month-old female Wistar rats were fed with diets containing twice the concentration of vitamin D (group 2) and of calcium (group 3) as in the usual rat chow. Follow-up to 24 months of age did not show significant differences between the enriched-diet groups and the controls (group 1) in terms of the vertebral body weight and protein content. Significantly higher bone mineral contents were found in groups 2 and 3 than were found in controls, as revealed by an increased bone mineral density (BMD: +62%, group 2; +48%, group 3) and vertebral calcium content (+73%, group 2; +84%, group 3). The vertebral alkaline phosphatase enzymatic activity was significantly lower in the enriched diet groups than in controls (-47%, group 2; -45%, group 3). The ratio alkaline phosphatase/acid phosphatase activity was markedly reduced in groups 2 and 3 (-57% and -59%, respectively), which might indicate a diminished rate of bone turnover. The trabecular bone volume (BV/TV) decreased in all groups during senescence, being significantly elevated in group 3 as compared to controls. Vitamin D and calcium dietary supplementations increase the axial mineral bone content in laboratory rats and might reduce the bone turnover. Their influence on the trabecular bone volume has yet to be examined.
Asunto(s)
Densidad Ósea/efectos de los fármacos , Calcio de la Dieta/farmacología , Vértebras Lumbares/efectos de los fármacos , Vitamina D/farmacología , Absorciometría de Fotón , Envejecimiento/patología , Fosfatasa Alcalina/metabolismo , Análisis de Varianza , Animales , Biomarcadores/sangre , Peso Corporal/efectos de los fármacos , Enfermedades Óseas Metabólicas/prevención & control , Calcio de la Dieta/administración & dosificación , Modelos Animales de Enfermedad , Femenino , Estudios de Seguimiento , Humanos , Vértebras Lumbares/enzimología , Vértebras Lumbares/fisiología , Osteoporosis Posmenopáusica/prevención & control , Ratas , Ratas Wistar , Vitamina D/administración & dosificaciónRESUMEN
The present study investigated the interactions of growth hormone (GH) and glucocorticoid on skeletal growth and bone structure in young mice. The purpose of this study was to examine the possible prevention by GH of the damage inflicted by dexamethasone (Dex) at sites of skeletal growth and ossification. Dex (1 mg/kg) with or without rat GH (rGH) or bovine GH (bGH), 1 mg/kg, was given for 4 weeks, from age 3-7 weeks, to female ICR mice. Tibiae, humerus, and vertebrae were analyzed morphometrically and biochemically. Growth, as determined by the mouse weight, tibial length, and humerus protein content was found to be compromised by dexamethasone. This was prevented by rGH or bGH. The epiphyseal growth plate width, trabecular bone volume, cortical bone width, mineral bone content, and alkaline and acid phosphatase activity were decreased by dexamethasone. These were prevented by rGH or by bGH. The findings of the present study suggest that in the mouse, GH can decrease or even avoid some of the pathological features in growing bones inflicted by high-dose glucocorticoid treatment.
Asunto(s)
Desarrollo Óseo/efectos de los fármacos , Huesos/efectos de los fármacos , Dexametasona/antagonistas & inhibidores , Hormona del Crecimiento/farmacología , Análisis de Varianza , Animales , Densidad Ósea/efectos de los fármacos , Huesos/anatomía & histología , Dexametasona/farmacología , Interacciones Farmacológicas , Femenino , Húmero/anatomía & histología , Procesamiento de Imagen Asistido por Computador , Vértebras Lumbares/anatomía & histología , Ratones , Ratones Endogámicos ICR , Tibia/anatomía & histologíaRESUMEN
Histomorphometric analysis of age-related structural changes in the brain was performed in CW1 female mice, 3, 9, 24 and 32 months of age. Cholinergic regions, such as the hippocampus, NBM and the medial habenula (MH) were investigated in more detail focusing on morphological parameters. The thickness of the frontoparietal cortex (FPC), and the surface area of the dorsal hippocampus and the MH were found to decrease significantly from 9 to 24 months of age. Except for the unique appearance of pseudo-cysts within the FPC, the structural changes culminated by 24 months. Cells' degeneration, in the CA3 hippocampal subfield, was noted already by 9 months of age whereas in other regions the cells' surface area decreased only between 9 and 24 months. Lipofuscin accumulation was most pronounced in the large neurons of the cortex, hippocampus and NBM at 24 months of age.
Asunto(s)
Envejecimiento/patología , Encéfalo/patología , Receptores Colinérgicos , Animales , Corteza Cerebral/patología , Gránulos Citoplasmáticos/patología , Femenino , Hipocampo/patología , Lipofuscina/análisis , Ratones , Degeneración Nerviosa , Receptores Colinérgicos/análisis , Sustancia Innominada/patología , Tálamo/patologíaRESUMEN
Cell cultures derived from young rat epiphyseal cartilage were grown for approximately 2 wk in BGJb medium supplemented with 10% fetal bovine serum to reach confluence. These cells were identified as chondrocytes as checked by morphology, the presence of alkaline phosphatase, and a positive type II collagen antibody reaction. The cells also responded to different hormonal treatment. Parathyroid hormone (PTH) increased cyclic AMP production by 50% within 15 min of treatment, whereas prostaglandin E2 (PGE2) caused an increase of 160%. Calcitonin (CT) did not affect cAMP production in these cells. DNA synthesis 24 h after hormonal treatment was increased by PTH (2.5-fold) and PGE2 (2-fold), but not by CT. Among the vitamin D metabolites, 24,25(OH)2D3 increased significantly the [3H]thymidine incorporation into DNA, whereas 1,25(OH)2D3 effect was minimal. These results provide evidence for the use of these cell cultures as a model for cartilage in vitro when studying biological and hormonal responsiveness.
Asunto(s)
Calcitonina/farmacología , Epífisis/metabolismo , Hormona Paratiroidea/farmacología , Prostaglandinas E/farmacología , Vitamina D/farmacología , 24,25-Dihidroxivitamina D 3 , Animales , Calcitriol/farmacología , Células Cultivadas , AMP Cíclico/biosíntesis , ADN/biosíntesis , Dihidroxicolecalciferoles/farmacología , Dinoprostona , Epífisis/efectos de los fármacos , RatasRESUMEN
The in vivo effects of elevated doses of picrotoxin, a gamma-aminobutyric acid (GABA) A-receptor antagonist, were studied in the skulls of weaning rats. Twenty-one-day-old male rats were treated daily with 2 mg/kg of pictroxin for a period of 3 weeks. This study revealed that chronic administration of the agent caused a reduction in bone formation in various growth sites in the skull along with a significant decrease in the calcium content and alkaline phosphatase activity in the mandible. Serum levels of calcium were unchanged, but the activity of alkaline phosphatase decreased. The decrease in bone alkaline phosphatase was accompanied by structural changes in the developing mandible. The latter was manifested by qualitative changes in the structure of ossification sites, in the appearance of the osteoblasts, and in the pattern of bone mineralization. These findings indicate that picrotoxin affects the normal growth of the craniofacial skeleton in an intact growing animal, probably because of central changes in GABA-ergic control on motor function along with possible alteration in corticosteroid secretion.
Asunto(s)
Mandíbula/crecimiento & desarrollo , Picrotoxina/farmacología , Receptores de GABA-A/fisiología , Cráneo/crecimiento & desarrollo , Fosfatasa Alcalina/metabolismo , Animales , Peso Corporal/efectos de los fármacos , Calcio/metabolismo , Masculino , Mandíbula/anatomía & histología , Mandíbula/efectos de los fármacos , Fósforo/metabolismo , Ratas , Ratas Endogámicas , Receptores de GABA-A/efectos de los fármacos , Convulsiones/inducido químicamente , Cráneo/efectos de los fármacos , DesteteRESUMEN
This study provides newer information concerning the extracellular matrix of neonatal condylar cartilage--a genuine representative of a secondary type of cartilage. In addition, the data presented hereby indicate that the condylar cartilage contains a population of progenitor cells that synthesise Type I collagen rather than Type II. Under normal conditions in vivo local biomechanical factors influence the progenitor cells to differentiate into cartilage cells and thereby to shift their synthetic pathway from Type I collagen to Type II collagen--the typical collagen of cartilage extracellular matrix. In the absence of such biomechanical effects the condylar progenitor cells seem to proceed with their inherent differentiation pathway and express an osteogenic phenotype (Fig. 21).
Asunto(s)
Animales Recién Nacidos/anatomía & histología , Matriz Extracelular/ultraestructura , Cóndilo Mandibular/ultraestructura , Animales , Calcio/metabolismo , Colágeno/metabolismo , Matriz Extracelular/metabolismo , Femenino , Técnica del Anticuerpo Fluorescente , Hipertrofia , Masculino , Cóndilo Mandibular/metabolismo , Ratones , Microscopía Electrónica , Minerales/análisis , Fósforo/análisisRESUMEN
Mandibular condyles of fetal mice 19 to 20 days in utero comprising clean cartilage and its perichondrium were cultured for up to 14 days, and their capacity to develop osteoid and to mineralize in vitro was examined. After 3 days in culture the cartilage of the mandibular condyle appeared to have lost its inherent structural characteristics, including its various cell layers: chondroprogenitor, chondroblastic, and hypertrophic cells. At that time interval no chondroblasts could be seen; instead, most of the cartilage consisted of hypertrophic chondrocytes. By that time, the surrounding perichondrium, which contains pluripotential mesenchymal stem cells, revealed the first signs of extracellular matrix enclosing type I collagen, bone alkaline phosphatase, osteonection, fibronectin, and bone sialoprotein as demonstrated by immunofluorescent techniques. Electron microscopic examinations of the newly formed matrix revealed foci of mineralization within and along collagen fibers as is normally observed during bone development. The composition of the latter mineral deposits resembled calcium pyrophosphate crystals. Following 14 days in culture larger portions of the condyle revealed signs of osseous matrix, yet the tissue reacted positively for type II collagen. Hence, the condylar cartilage, a genuine representative of secondary-type cartilage, elaborated in vitro a unique type of bone that would be most appropriately defined as chondroid bone. Biochemical assays indicated that the de novo formation of chondroid bone was correlated with changes in alkaline phosphatase activity and 45Ca incorporation. The findings of the present study imply that mesenchymal stem cells that ordinarily differentiate into cartilage possess the capacity to differentiate into osteogenic cells and form chondroid bone.
Asunto(s)
Desarrollo Óseo , Mandíbula/embriología , Animales , Calcio/metabolismo , Cartílago/embriología , Colágeno/metabolismo , Matriz Extracelular/ultraestructura , Mesodermo/citología , Ratones , Microscopía Electrónica , Técnicas de Cultivo de Órganos , Fósforo/metabolismo , Factores de TiempoRESUMEN
Mandibular condyles of fetal mice 19-20 days in utero were kept in a serum-free organ culture system for up to 14 days and were investigated for their capacity to develop osteoid and to mineralize in vitro. After 3 days in culture, the cartilage of the mandibular condyle appeared to have maintained all its inherent structural characteristics, including its various cell layers: chondroprogenitor, chondroblastic, and hypertrophic. After 7-9 days in culture, no chondroblasts could be seen; instead, most of the cartilage consisted of hypertrophic chondrocytes. In addition, various areas throughout the explant revealed the appearance of osteoidlike material. The process of matrix mineralization progressed with time, and by the 14th day new bonelike material was found to occupy a larger portion of the explant. The newly formed matrix reacted positively with antibodies against type I and type III collagens, as well as against bone alkaline phosphatase. Electron microscopic examination showed that the mineralization appeared to be associated with collagen fibers as well as the matrix vesicles. In composition, the in vitro-formed mineral deposits resembled hydroxyapatite crystals. Biochemical assays indicated that the newly formed tissue reacted strongly for alkaline phosphatase and incorporated 45Ca. The findings of the present study imply that fetal condylar cartilage possesses the potential to develop in vitro osseouslike tissue even in a system that is serum-free. Due to the fact that the newly formed extracellular matrix mineralized and reacted positively to bone markers as well as to cartilage macromolecules, it would seem justifiable to define the new tissue as chondroid bone.
Asunto(s)
Cartílago/embriología , Cóndilo Mandibular/embriología , Fosfatasa Alcalina/metabolismo , Animales , Cartílago/metabolismo , Cartílago/ultraestructura , Colágeno/metabolismo , Medios de Cultivo , Técnicas In Vitro , Cóndilo Mandibular/metabolismo , Cóndilo Mandibular/ultraestructura , Ratones , Microscopía Electrónica , Minerales/metabolismoRESUMEN
A case of mandibular actinomycosis, secondary to a compound fracture in an alcoholic patient, is described. The factors that apparently enhance the development of this disease are discussed.